It takes a village to raise a child, but what about shape-shifting tumors? Can they be corralled into submission? KI faculty members Douglas Lauffenburger and Michael Hemann are teaming up to create detailed profiles of tumor behavior, including their variable responsiveness to treatment, with an eye toward overcoming drug resistance and transforming tumor development models. Their approach may just be the discipline the field is calling for!